Company profile
BG Medicine, Inc.
OTC: BGMD · Healthcare · Medical - Instruments & Supplies
#823 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 28
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, listing tenure · ↓ market scale, Altman-Z
Methodology →Revenue TTM
$1.6M
Rev growth YoY (TTM)
-43.8%
Net income (FY)
-$5.3M
Employees
5
as of 2026-08-31
Market cap
$1.1k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.6M$1.6M2015
Net income-$5.3M-$5.3M2015
Operating income-$4.6M-$4.6M2015
Total assets$2.1M$2.1M2015
Liabilities$4.1M$4.1M2015
Equity-$2.0M-$2.0M2015
Revenue trend
FY2008 – FY2015 · USD
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is BG Medicine, Inc.’s revenue?
BG Medicine, Inc. booked $1.6M in FY2015 revenue, contracting 44% year over year — slower than 79% of Healthcare companies we track, at a -338.6% net margin.
Peers · Healthcare
EBR Systems, Inc.34DJames E. Wagner Cultivation Corporation——Cannabis Global Inc.——Acura Pharmaceuticals, Inc.——Celldex Therapeutics, Inc.58COrthometrix, Inc.——Neighbors
Middlesex →Key facts
CEOStephen Hall
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersWaltham, MA
ExchangeOTC: BGMD
Employees5
IPO date2011-02-04
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.